TGF-β secretion from Treg cells can regulate CTL function and reduce anti-tumor immunity, since an almost complete suppression of CD8-mediated cytolytic activity was found to be essentially dependent on TGF-β signaling, and CD8+ cells with a dominant negative TGF-β receptor were resistant to this suppression (57). Here, TGFB1 is linked to neoplasm.